Integral Health Asset Management, LLC Blueprint Medicines Corp Transaction History

Integral Health Asset Management, LLC

$1.12 Billion
Q4 2024

A detailed history of Integral Health Asset Management, LLC transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Integral Health Asset Management, LLC holds 275,000 shares of BPMC stock, worth $25.4 Million. This represents 2.14% of its overall portfolio holdings.

Number of Shares

275,000

Previous 290,000 5.17%

Holding current value

$25.4 Million

Previous $26.8 Million 10.55%

% of portfolio

2.14%

Previous 3.15%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$82.48 - $101.39 $1.24 Million - $1.52 Million	-15,000 Reduced 5.17%	275,000 $24 Million
Q3 2024 Nov 14, 2024	SELL	$84.1 - $120.5 $4.21 Million - $6.03 Million	-50,000 Reduced 14.71%	290,000 $26.8 Million
Q2 2024 Aug 14, 2024	BUY	$85.18 - $108.78 $11.1 Million - $14.1 Million	130,000 Added 61.9%	340,000 $36.6 Million
Q1 2024 May 15, 2024	BUY	$73.17 - $99.79 $5.12 Million - $6.99 Million	70,000 Added 50.0%	210,000 $19.9 Million
Q4 2023 Feb 14, 2024	BUY	$43.96 - $92.84 $3.96 Million - $8.36 Million	90,000 Added 180.0%	140,000 $12.9 Million
Q3 2023 Nov 14, 2023	BUY	$46.9 - $66.0 $2.35 Million - $3.3 Million	50,000 New	50,000 $2.51 Million
Q3 2022 Nov 14, 2022	SELL	$49.93 - $77.7 $1.85 Million - $2.87 Million	-37,000 Reduced 28.46%	93,000 $6.13 Million
Q2 2022 Aug 03, 2022	SELL	$45.23 - $70.15 $1.04 Million - $1.61 Million	-23,000 Reduced 15.03%	130,000 $6.57 Million
Q1 2022 May 12, 2022	BUY	$54.1 - $110.08 $4.22 Million - $8.59 Million	78,000 Added 104.0%	153,000 $9.77 Million
Q4 2021 Feb 02, 2022	SELL	$94.25 - $115.99 $2.17 Million - $2.67 Million	-23,000 Reduced 23.47%	75,000 $8.03 Million
Q3 2021 Nov 12, 2021	SELL	$80.98 - $109.47 $161,960 - $218,940	-2,000 Reduced 2.0%	98,000 $10.1 Million
Q2 2021 Aug 30, 2021	SELL	$82.78 - $101.0 $8.28 Million - $10.1 Million	-100,000 Reduced 50.0%	100,000 $8.8 Million
Q2 2021 Aug 13, 2021	BUY	$82.78 - $101.0 $6.83 Million - $8.33 Million	82,500 Added 70.21%	200,000 $17.6 Million
Q1 2021 May 10, 2021	BUY	$90.71 - $108.28 $2.95 Million - $3.52 Million	32,500 Added 38.24%	117,500 $11.4 Million
Q4 2020 Feb 16, 2021	SELL	$92.08 - $124.48 $1.84 Million - $2.49 Million	-20,000 Reduced 19.05%	85,000 $9.53 Million
Q3 2020 Nov 16, 2020	SELL	$66.45 - $92.7 $332,250 - $463,500	-5,000 Reduced 4.55%	105,000 $9.73 Million
Q2 2020 Aug 14, 2020	BUY	$57.09 - $79.27 $2.85 Million - $3.96 Million	50,000 Added 83.33%	110,000 $8.58 Million
Q1 2020 May 15, 2020	BUY	$48.11 - $82.22 $1.92 Million - $3.29 Million	40,000 Added 200.0%	60,000 $3.51 Million
Q4 2019 Feb 13, 2020	BUY	$66.73 - $82.59 $1.33 Million - $1.65 Million	20,000 New	20,000 $1.6 Million

Others Institutions Holding BPMC

# of Institutions

380

Shares Held

65.9M

Call Options Held

1.6M

Put Options Held

1.41M

View Full List

About Blueprint Medicines Corp

Ticker BPMC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,719,600
Market Cap $5.51B
Description
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...

More about BPMC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Integral Health Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Integral Health Asset Management, LLC with notifications on news.

Account

Integral Health Asset Management, LLC Blueprint Medicines Corp Transaction History